EXPERIENCE OF TREATMENT WITH RITUXIMAB IN PATIENT WITH SYSTEMIC TYPE OF JUVENILE RHEUMATOID ARTHRITIS
<em>The article gives a case report on patient with severe systemic type of juvenile arthritis, refractory to treatment with classical immuno suppressants and blocker of tumor necrotizing factor Successive application of biological agent — rituximab was described. In 9 weeks, extra articular s...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2009-01-01
|
| Series: | Вопросы современной педиатрии |
| Online Access: | http://vsp.spr-journal.ru:80/jour/article/view/1131 |
| _version_ | 1797719705946947584 |
|---|---|
| author | K.B. Isaeva E.I. Alexeeva R.V. Denisova T.M. Bzarova S.I. Valieva A.O. Lisitsin E.Yu. Gudkova E.L. Semikina E.A. Kopyl'tsova |
| author_facet | K.B. Isaeva E.I. Alexeeva R.V. Denisova T.M. Bzarova S.I. Valieva A.O. Lisitsin E.Yu. Gudkova E.L. Semikina E.A. Kopyl'tsova |
| author_sort | K.B. Isaeva |
| collection | DOAJ |
| description | <em>The article gives a case report on patient with severe systemic type of juvenile arthritis, refractory to treatment with classical immuno suppressants and blocker of tumor necrotizing factor Successive application of biological agent — rituximab was described. In 9 weeks, extra articular symptoms of disease and acute inflammatory lesions in joints were stopped, and functional activity of child increased. Presented case report demonstrates high effectiveness of rituximab: patient with severe systemic type of juvenile arthritis has clinical and laboratory remission of disease during 12 months.</em><br /><strong><em>Key words: children, juvenile rheumatoid arthritis, rituximab.</em></strong><br /><span style="text-decoration: underline;"><em>(<em><em><em>Voprosy sovremennoi pediatrii — </em></em></em>Current Pediatrics. 2009;8(3):<em>132-138</em>)</em></span> |
| first_indexed | 2024-03-12T09:08:48Z |
| format | Article |
| id | doaj.art-45163a9333254d5eafa945393a9f8b03 |
| institution | Directory Open Access Journal |
| issn | 1682-5527 1682-5535 |
| language | English |
| last_indexed | 2024-03-12T09:08:48Z |
| publishDate | 2009-01-01 |
| publisher | "Paediatrician" Publishers LLC |
| record_format | Article |
| series | Вопросы современной педиатрии |
| spelling | doaj.art-45163a9333254d5eafa945393a9f8b032023-09-02T15:04:49Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352009-01-01831321381132EXPERIENCE OF TREATMENT WITH RITUXIMAB IN PATIENT WITH SYSTEMIC TYPE OF JUVENILE RHEUMATOID ARTHRITISK.B. Isaeva0E.I. Alexeeva1R.V. Denisova2T.M. Bzarova3S.I. Valieva4A.O. Lisitsin5E.Yu. Gudkova6E.L. Semikina7E.A. Kopyl'tsova8Scientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow<em>The article gives a case report on patient with severe systemic type of juvenile arthritis, refractory to treatment with classical immuno suppressants and blocker of tumor necrotizing factor Successive application of biological agent — rituximab was described. In 9 weeks, extra articular symptoms of disease and acute inflammatory lesions in joints were stopped, and functional activity of child increased. Presented case report demonstrates high effectiveness of rituximab: patient with severe systemic type of juvenile arthritis has clinical and laboratory remission of disease during 12 months.</em><br /><strong><em>Key words: children, juvenile rheumatoid arthritis, rituximab.</em></strong><br /><span style="text-decoration: underline;"><em>(<em><em><em>Voprosy sovremennoi pediatrii — </em></em></em>Current Pediatrics. 2009;8(3):<em>132-138</em>)</em></span>http://vsp.spr-journal.ru:80/jour/article/view/1131 |
| spellingShingle | K.B. Isaeva E.I. Alexeeva R.V. Denisova T.M. Bzarova S.I. Valieva A.O. Lisitsin E.Yu. Gudkova E.L. Semikina E.A. Kopyl'tsova EXPERIENCE OF TREATMENT WITH RITUXIMAB IN PATIENT WITH SYSTEMIC TYPE OF JUVENILE RHEUMATOID ARTHRITIS Вопросы современной педиатрии |
| title | EXPERIENCE OF TREATMENT WITH RITUXIMAB IN PATIENT WITH SYSTEMIC TYPE OF JUVENILE RHEUMATOID ARTHRITIS |
| title_full | EXPERIENCE OF TREATMENT WITH RITUXIMAB IN PATIENT WITH SYSTEMIC TYPE OF JUVENILE RHEUMATOID ARTHRITIS |
| title_fullStr | EXPERIENCE OF TREATMENT WITH RITUXIMAB IN PATIENT WITH SYSTEMIC TYPE OF JUVENILE RHEUMATOID ARTHRITIS |
| title_full_unstemmed | EXPERIENCE OF TREATMENT WITH RITUXIMAB IN PATIENT WITH SYSTEMIC TYPE OF JUVENILE RHEUMATOID ARTHRITIS |
| title_short | EXPERIENCE OF TREATMENT WITH RITUXIMAB IN PATIENT WITH SYSTEMIC TYPE OF JUVENILE RHEUMATOID ARTHRITIS |
| title_sort | experience of treatment with rituximab in patient with systemic type of juvenile rheumatoid arthritis |
| url | http://vsp.spr-journal.ru:80/jour/article/view/1131 |
| work_keys_str_mv | AT kbisaeva experienceoftreatmentwithrituximabinpatientwithsystemictypeofjuvenilerheumatoidarthritis AT eialexeeva experienceoftreatmentwithrituximabinpatientwithsystemictypeofjuvenilerheumatoidarthritis AT rvdenisova experienceoftreatmentwithrituximabinpatientwithsystemictypeofjuvenilerheumatoidarthritis AT tmbzarova experienceoftreatmentwithrituximabinpatientwithsystemictypeofjuvenilerheumatoidarthritis AT sivalieva experienceoftreatmentwithrituximabinpatientwithsystemictypeofjuvenilerheumatoidarthritis AT aolisitsin experienceoftreatmentwithrituximabinpatientwithsystemictypeofjuvenilerheumatoidarthritis AT eyugudkova experienceoftreatmentwithrituximabinpatientwithsystemictypeofjuvenilerheumatoidarthritis AT elsemikina experienceoftreatmentwithrituximabinpatientwithsystemictypeofjuvenilerheumatoidarthritis AT eakopyltsova experienceoftreatmentwithrituximabinpatientwithsystemictypeofjuvenilerheumatoidarthritis |